Clinuvel Pharmaceuticals Ltd.

1D

1W

1M

3M

YTD

1Y

5Y

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLVLY and other ETFs, options, and stocks.

About CLVLY

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug.

CEO

Philippe Jacques Wolgen

CEOPhilippe Jacques Wolgen

Employees

—

Employees—

Headquarters

Melbourne, Victoria (VIC)

HeadquartersMelbourne, Victoria (VIC)

Founded

1999

Founded1999

Employees

—

Employees—

CLVLY Key Statistics

Market cap

408.58M

Market cap408.58M

Price-Earnings ratio

17.89

Price-Earnings ratio17.89

Dividend yield

0.31%

Dividend yield0.31%

Average volume

1.67K

Average volume1.67K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$9.00

52 Week high$9.00

52 Week low

$6.00

52 Week low$6.00

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.